Some of the peptide may be broken down before it can exert its full effect on systemic tissues outside the gut
For instance, semaglutide has been approved and is being researched for indications including obesity, T2DM, reducing cardiovascular risk, chronic kidney disease, NAFLD, and AD, indicating that the development of new indications could provide new growth opportunities for GLP-1 drugs
Wait it out
Hellman L, Nakada F, Zumoff B, Fukushima D, Bradlow HL, Gallagher TF
That experience reinforced an important point: two bottles with similar Supplement Facts panels may not represent the same manufacturing quality
BPC-157 concentration versus vascular endothelial cell growth Source: PubMed Cell culture research has effectively demonstrated vascular running secondary to BPC-157 administration